Tramiprosate

DB06527InvestigationalSmall molecule

Investigated for use/treatment in strokes and alzheimer's disease.

Chemical structure of Tramiprosate
Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in strokes and alzheimer's disease.Curator reviewed
Formula / weight
C3H9NO3S · 139.173 g/mol (avg)
Also known as
Homotaurine
Code names
NC-531 · NSC-77071

Resolves to

Compound
UNII5K8EAX0G53CAS3687-18-1ChEMBLCHEMBL149082ChEBI1457KEGGD06202
Clinical / RWD
RxNorm1374845
Structure
InChIKeySNKZJIOFVMKAOJ-UHFFFAOYSA-NSMILESNCCCS(O)(=O)=O
Targets
P05067APP

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
809Drug interactionsStructured to mechanism, not free text
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Tramiprosate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In